89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo-Reference-Cited by-同舟云学术

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

Published:2019-05-30 Issue:12 Volume:60 Page:1825-1832
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Jauw Yvonne W.S.,O’Donoghue Joseph A.,Zijlstra Josée M.,Hoekstra Otto S.,Menke-van der Houven van Oordt C. Willemien,Morschhauser Franck,Carrasquillo Jorge A.,Zweegman Sonja,Pandit-Taskar Neeta,Lammertsma Adriaan A.,van Dongen Guus. A.M.S.,Boellaard Ronald,Weber Wolfgang A.,Huisman Marc C.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference24 articles.

1. The Use of Microdosing in the Development of Small Organic and Protein Therapeutics

2. Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: what can we learn from initial clinical trials?;Jauw;Front Pharmacol.,2016

3. Forward to the Past: The Case for Quantitative PET Imaging

4. 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer

5. ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy;Nuclear Medicine and Biology;2024-09

2. Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine;Chemical & Biomedical Imaging;2024-08-22

3. Construction of [⁸⁹Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells;Molecular Pharmaceutics;2024-06-28

4. The development process of ‘fit-for-purpose’ imaging biomarkers to characterize the tumor microenvironment;Frontiers in Medicine;2024-05-16

5. Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE;EJNMMI Radiopharmacy and Chemistry;2024-05-08